Meet Our People

Our diverse team of experts provide rigorous, independent reviews of investment opportunities, and bring insights that support the journey from bench to clinic.


Jayne Spink
Sonja Lawrence
Head of Business Development
Oliver Kemp
CEO of Prostate Cancer Research

Translational Scientific Advisory Committee

(TSAC)- TSAC conducts independent reviews of investment proposals on the basis of a proposals scientific quality, commercial potential and strategic fit.

Special Advisors